Published in Appl Microbiol on November 01, 1969
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Chromosomal genetics of Pseudomonas. Microbiol Rev (1979) 13.65
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun (1983) 6.24
Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa. J Bacteriol (1984) 6.22
Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J Bacteriol (1973) 6.10
Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol (2001) 4.09
Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate. Infect Immun (1981) 3.84
Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun (1980) 3.23
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev (1991) 2.87
High osmolarity is a signal for enhanced algD transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains. J Bacteriol (1989) 2.46
Pseudomonas aeruginosa: immune status in patients with cystic fibrosis. Infect Immun (1972) 1.99
Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect Immun (1987) 1.96
Method for gene replacement in Pseudomonas aeruginosa used in construction of recA mutants: recA-independent instability of alginate production. J Bacteriol (1985) 1.90
Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas. J Clin Microbiol (1975) 1.81
Characterization of temporal protein production in Pseudomonas aeruginosa biofilms. J Bacteriol (2005) 1.81
High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrob Agents Chemother (2007) 1.74
Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun (1983) 1.68
Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins. Antimicrob Agents Chemother (1981) 1.66
Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains. J Clin Microbiol (1982) 1.40
Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus. PLoS One (2017) 1.39
Alginate production by clinical nonmucoid Pseudomonas aeruginosa strains. J Clin Microbiol (1987) 1.28
Cif is negatively regulated by the TetR family repressor CifR. Infect Immun (2008) 1.27
Partial purification and characterization of a polymannuronic acid depolymerase produced by a mucoid strain of Pseudomonas aeruginosa isolated from a patient with cystic fibrosis. Appl Environ Microbiol (1985) 1.23
Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis. Clin Infect Dis (2014) 1.22
Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements. J Bacteriol (1994) 1.21
Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis. J Clin Microbiol (1984) 1.17
Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics. Antimicrob Agents Chemother (1984) 1.12
The influence of human respiratory epithelia on Pseudomonas aeruginosa gene expression. Microb Pathog (2006) 1.11
Selection of nonmucoid derivatives of mucoid Pseudomonas aeruginosa is strongly influenced by the level of iron in the culture medium. Infect Immun (1982) 1.07
Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis. Infect Immun (1992) 1.04
Positive correlation of algD transcription to lasB and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Infect Immun (1997) 1.02
Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice. Infect Immun (1987) 0.98
Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect Immun (2006) 0.97
Co-regulation of {beta}-lactam resistance, alginate production and quorum sensing in Pseudomonas aeruginosa. J Med Microbiol (2010) 0.95
Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung. PLoS One (2013) 0.94
Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner. J Bacteriol (2009) 0.86
Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator. Pathog Dis (2015) 0.86
Pyocyanin-induced mucin production is associated with redox modification of FOXA2. Respir Res (2013) 0.83
Toxic activity against alveolar macrophages of products of Pseudomonas aeruginosa isolated from respiratory and non-respiratory sites. J Hyg (Lond) (1976) 0.82
Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation and O-polysaccharide modification. Infect Immun (2015) 0.81
Which bacterial biofilm exopolysaccharide is preferred, Psl or alginate? J Bacteriol (2013) 0.81
Adaptation to Parasites and Costs of Parasite Resistance in Mutator and Nonmutator Bacteria. Mol Biol Evol (2015) 0.80
The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes. Front Cell Infect Microbiol (2014) 0.77
Complete Genome Sequence of Pseudomonas aeruginosa Mucoid Strain FRD1, Isolated from a Cystic Fibrosis Patient. Genome Announc (2015) 0.76
Pseudomonas aeruginosa AmrZ Binds to Four Sites in the algD Promoter, Inducing DNA-AmrZ Complex Formation and Transcriptional Activation. J Bacteriol (2016) 0.75
COMPARISON OF SOME PROPERTIES OF PSEUDOMONAS AERUGINOSA ISOLATED FROM INFECTIONS IN PERSONS WITH AND WITHOUT CYSTIC FIBROSIS. J Bacteriol (1964) 4.04
Increasing incidence of encapsulated Pseudomonas aeruginosa strains. Am J Clin Pathol (1967) 1.88
ENCAPSULATED PSEUDOMONAS AERUGINOSA (PSEUDOMONAS AERUGINOSA MUCOSUS) STRAINS. J Bacteriol (1965) 1.87
Mucoid Pseudomonas aeruginosa in patients with chronic illnesses. Lancet (1971) 3.23
Pseudomonas aeruginosa: immune status in patients with cystic fibrosis. Infect Immun (1972) 1.99
Structure and ultrastructure of the labial salivary glands in patients with cystic fibrosis. J Clin Pathol (1971) 1.01
Autosensitivity of Pseudomonas aeruginosa to its own pyocin. Infect Immun (1972) 0.98
Cystic fibrosis: in vivo reversal of the ciliostatic character of serum and parotid secretions by heparin. Nat New Biol (1973) 0.80
New anti-Pseudomonas agent isolated from a marine vibrio. J Bacteriol (1968) 0.79
Cystic fibrosis: reversal of ciliary inhibition in serum and saliva by heparin. Tex Rep Biol Med (1973) 0.75
Cystic fibrosis: in vitro reversal of the ciliostatic character or serum and salivary secretions by heparin. Nat New Biol (1973) 0.75
Nasal and paranasal sinus polyps--a suspected new etiological co-factor. Laryngoscope (1972) 0.75